BBR Partners Portfolio holdings
BBR Partners is a multi-family office that advises high net worth families and individuals, and it may spread their money across a range of outside investment managers and strategies. It was founded in 2000 by Brett Barth, Arthur Black and Evan Roth, all former Goldman Sachs executives; Roth had also run private accounts at Global Asset Management. Barth and Roth share the chief executive role and are the principal controllers of the firm's holding company. The firm does due diligence on the managers it hires, and it runs its own BBR Funds that pool client money in diversified portfolios of alternative and other investments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown-Forman Class A
BF.A
|
+$58.2M |
| 2 |
Blackstone
BX
|
+$10.9M |
| 3 |
GE Aerospace
GE
|
+$3.59M |
| 4 |
JPMorgan Chase
JPM
|
+$3.57M |
| 5 |
Bank of America
BAC
|
+$3.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$44.1M |
| 2 |
Vanguard Total World Stock ETF
VT
|
+$26M |
| 3 |
ESRX
Express Scripts Holding
ESRX
|
+$9.48M |
| 4 |
Humana
HUM
|
+$1.03M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$297K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 59.76% |
| 2 | Miscellaneous | 23.28% |
| 3 | Financials | 10.81% |
| 4 | Healthcare | 2.96% |
| 5 | Industrials | 0.95% |
Similar funds
BBR Partners's Q3 2014 Portfolio in Review
As of Q3 2014, BBR Partners held 69 positions worth $661M, up 1.4% from $652M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
BBR Partners's Q3 2014 filing shows 17 new, 14 increased, 8 reduced and 5 closed positions. Its largest new stake was Blackstone: 335,987 shares worth $10.4M. The largest sale was Merck, an estimated $44.1M.
By sector, the portfolio is most concentrated in Consumer Staples at 60% of assets, up from 54% a quarter earlier, followed by Miscellaneous and Financials.
- BBR Partners's largest Q3 2014 buy was Blackstone: 335,987 shares worth $10.4M.
- BBR Partners added most to Brown-Forman Class A in Q3 2014, an estimated $58.2M increase.
- BBR Partners's biggest Q3 2014 reduction was Humana, cutting an estimated $1.03M.
- BBR Partners fully exited Merck in Q3 2014, selling an estimated $44.1M.
- BBR Partners's ten largest holdings make up 93% of its $661M portfolio in Q3 2014.
- BBR Partners opened 17 new positions and closed 5 in Q3 2014.
- BBR Partners's portfolio value rose 1.4% quarter-over-quarter to $661M.
Based on BBR Partners's 13F filing for Q3 2014, filed 12 Nov 2014.